Cantor Fitzgerald Comments on CATX FY2024 Earnings
Perspective Therapeutics, Inc. (NYSE:CATX – Free Report) – Stock analysts at Cantor Fitzgerald issued their FY2024 earnings per share (EPS) estimates for Perspective Therapeutics in a report issued on Tuesday, March 4th. Cantor Fitzgerald analyst L. Watsek forecasts that the company will post earnings of ($0.90) per share for the year. Cantor Fitzgerald currently has […]
